Suppressive influences of IFN-α on IL-17 expression in human CD4+ T cells

Clinical Immunology

Volumn 134, Issue 3, 2010, Pages 340-344

  Hirohata, Shunsei ^a   Shibuya, Hideki ^b   Tejima, Satoko ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKYO TEISHIN HOSPITAL   (Japan)

Author keywords

Fox P3; Human; IFN ; IL 17; RORC; Th17

Indexed keywords

CD3 ANTIBODY; INTERLEUKIN 17; INTERLEUKIN 6; MESSENGER RNA; RECOMBINANT ALPHA2 INTERFERON; RETINOIC ACID RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ACCESSORY CELL; ARTICLE; CD4+ T LYMPHOCYTE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; HUMAN; HUMAN CELL; IMMOBILIZED CELL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH17 CELL;

CD4-POSITIVE T-LYMPHOCYTES; DOWN-REGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INTERFERON-ALPHA; INTERLEUKIN-17; INTERLEUKIN-6; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STATISTICS, NONPARAMETRIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 76049128115     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2009.11.012     Document Type: Article

References (21)

1. Constant S.L., and Bottomly K. Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches. Annu. Rev. Immunol. 15 (1997) 297-322
2. Schmidt-Weber C.B., Akdis M., and Akdis C.A. TH17 cells in the big picture of immunology. J. Allergy Clin. Immunol. 120 (2007) 247-254
3. + T helper cells. Cell 126 (2006) 1121-1133
4. Ouyang W., Kolls J.K., and Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 28 (2008) 454-467
5. Takatori H., Kanno Y., Chen Z., and O'Shea J.J. New complexities in helper T cell fate determination and the implications for autoimmune diseases. Mod. Rheumatol. 18 (2008) 533-541
6. Chi W., Zhu X., Yang P., Liu X., Lin X., Zhou H., et al. Upregulated IL-23 and IL-17 in Behçet patients with active uveitis. Invest. Ophthalmol. Vis. Sci. 49 (2008) 3058-3064
7. Shibuya H., Nagai T., Ishii A., Yamamoto K., and Hirohata S. Differential regulation of Th1 responses and CD154 expression in human CD4+ T cells by IFN-alpha. Clin. Exp. Immunol. 132 (2003) 216-224
8. Shibuya H., and Hirohata S. Differential effects of IFN-alpha on the expression of various TH2 cytokines in human CD4+ T cells. J. Allergy Clin. Immunol. 116 (2005) 205-212
9. Simon H.U., Seelbach H., Ehmann R., and Schmitz M. Clinical and immunological effects of low-dose IFN-α treatment in patients with corticosteroid-resistant asthma. Allergy 58 (2003) 1250-1255
10. Gueudry J., Wechsler B., Terrada C., Gendron G., Cassoux N., Fardeau C., et al. Interferon-alpha in the management of patients with Behcet's disease. Am. J. Ophthalmol. 146 (2008) 837-844
11. Meyers J.A., Mangini A.J., Nagai T., Roff C.F., Sehy D., van Seventer G.A., et al. Blockade of TLR9 agonist-induced type I interferons promotes inflammatory cytokine IFN-gamma and IL-17 secretion by activated human PBMC. Cytokine 35 (2006) 235-246
12. Moschen A.R., Geiger S., Krehan I., Kaser A., and Tilg H. Interferon-alpha controls IL-17 expression in vitro and in vivo. Immunobiology 213 (2008) 779-787
13. He Y.W., Deftos M.L., Ojala E.W., and Bevan M.J. RORgammat, a novel isoform of an orphan receptor, negatively regulates Fas ligand expression and IL-2 production in T cells. Immunity 9 (1998) 797-806
14. Hirohata S., and Miyamoto T. Elevated levels of interleukin-6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system involvement. Arthritis Rheum. 33 (1990) 644-649
15. Veldhoen M., Hocking R.J., Atkins C.J., Locksley R.M., and Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24 (2006) 179-189
16. Milner J.D., Brenchley J.M., Laurence A., Freeman A.F., Hill B.J., Elias K.M., et al. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 452 (2008) 773-776
17. Laurence A., Tato C.M., Davidson T.S., Kanno Y., Chen Z., Yao Z., et al. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 26 (2007) 371-381
18. Humpoliková-Adámková L., Kovarík J., Dusek L., Lauerová L., Boudný V., Fait V., et al. Interferon-alpha treatment may negatively influence disease progression in melanoma patients by hyperactivation of STAT3 protein. Eur. J. Cancer 45 (2009) 1315-1323
19. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22 (2004) 531-562
20. Fontenot J.D., Gavin M.A., and Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4 (2003) 330-336
21. Zhou L., Lopes J.E., Chong M.M., Ivanov I.I., Min R., Victora G.D., et al. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 453 (2008) 236-240